A study to test if aleglitazar has a positive effect on the heart of patients with Type 2 diabetes and without cardiac disease, looking at the way the heart processes energy and fat

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate if aleglitazar improves cardiac energetics, by means of MRS, in uncomplicated T2D patients with no history of CAD, after 6 weeks of treatment

Critère d'inclusion

Type 2 diabetes mellitus

Liens

euctr
ictrp